Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We demonstrate the genetic transformation of
Chlamydia pneumoniae
using a plasmid shuttle vector system which generates stable transformants. The equine
C. pneumoniae
N16 isolate harbors the 7.5-kb plasmid pCpnE1. We constructed the plasmid vector pRSGFPCAT-Cpn containing a pCpnE1 backbone, plus the red-shifted green fluorescent protein (RSGFP), as well as the
chloramphenicol acetyltransferase
(
CAT
) gene used for the selection of plasmid shuttle vector-bearing
C. pneumoniae
transformants. Using the pRSGFPCAT-Cpn plasmid construct, expression of RSGFP in koala isolate
C. pneumoniae
LPCoLN was demonstrated. Furthermore, we discovered that the human cardiovascular isolate
C. pneumoniae
CV-6 and the human community-acquired pneumonia-associated
C. pneumoniae
IOL
-207 could also be transformed with pRSGFPCAT-Cpn. In previous studies, it was shown that
Chlamydia
spp. cannot be transformed when the plasmid shuttle vector is constructed from a different plasmid backbone to the homologous species. Accordingly, we confirmed that pRSGFPCAT-Cpn could not cross the species barrier in plasmid-bearing and plasmid-free
C. trachomatis
,
C. muridarum
,
C. caviae
,
C. pecorum
, and
C. abortus
However, contrary to our expectation, pRSGFPCAT-Cpn did transform
C. felis
Furthermore, pRSGFPCAT-Cpn did not recombine with the wild-type plasmid of
C. felis
Taken together, we provide for the first time an easy-to-handle transformation protocol for
C. pneumoniae
that results in stable transformants. In addition, the vector can cross the species barrier to
C. felis
, indicating the potential of horizontal pathogenic gene transfer via a plasmid.
IMPORTANCE
The absence of tools for the genetic manipulation of
C. pneumoniae
has hampered research into all aspects of its biology. In this study, we established a novel reproducible method for
C. pneumoniae
transformation based on a plasmid shuttle vector system. We constructed a
C. pneumoniae
plasmid backbone shuttle vector, pRSGFPCAT-Cpn. The construct expresses the red-shifted green fluorescent protein (RSGFP) fused to
chloramphenicol acetyltransferase
in
C. pneumoniae
C. pneumoniae
transformants stably retained pRSGFPCAT-Cpn and expressed RSGFP in epithelial cells, even in the absence of chloramphenicol. The successful transformation in
C. pneumoniae
using pRSGFPCAT-Cpn will advance the field of chlamydial genetics and is a promising new approach to investigate gene functions in
C. pneumoniae
biology. In addition, we demonstrated that pRSGFPCAT-Cpn overcame the plasmid species barrier without the need for recombination with an endogenous plasmid, indicating the potential probability of horizontal chlamydial pathogenic gene transfer by plasmids between chlamydial species.
...
PMID:The Genetic Transformation of Chlamydia pneumoniae. 3030 18